Abstract
Barth syndrome (BTHS) is a rare X-linked disorder characterized by cardiomyopathy, short stature, neutropenia, and 3-methylglutaconic aciduria. Mutations have been identified in the TAZ (G4.5) gene in patients with BTHS. This article presents a mutation analysis of this gene in a Japanese boy with cardiomyopathy with abnormal mitochondria, cyclic neutropenia, and 3-methylglutaconic aciduria (type 2). The analysis revealed a novel missense mutation (R94S) caused by a single nucleotide substitution (C-to-A) in this patient.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
Received: November 30, 2001 / Accepted: February 9, 2002
Rights and permissions
About this article
Cite this article
Sakamoto, O., Kitoh, T., Ohura, T. et al. Novel missense mutation (R94S) in the TAZ (G4.5) gene in a Japanese patient with Barth syndrome. J Hum Genet 47, 229–231 (2002). https://doi.org/10.1007/s100380200030
Issue Date:
DOI: https://doi.org/10.1007/s100380200030
This article is cited by
-
Mis-sesnse mutations in Tafazzin (TAZ) that escort to mild clinical symptoms of Barth syndrome is owed to the minimal inhibitory effect of the mutations on the enzyme function: In-silico evidence
Interdisciplinary Sciences: Computational Life Sciences (2015)
-
Natural history of Barth syndrome: a national cohort study of 22 patients
Orphanet Journal of Rare Diseases (2013)